Abstract
Objectives: The dermal absorption of the solvent N-methyl-2-pyrrolidone (NMP) and its elimination in urine was investigated in an experimental study. Methods: Seven volunteers were exposed to 1045 mg of liquid NMP under occlusive conditions for 2 h. Urine was collected before, during and up to 72 h after the exposure and analysed for NMP by GC/MS after liquid–liquid extraction. Additionally, the remaining NMP in the pads was determined to estimate the total dermal uptake. Results: The concentration of NMP in urine increased rapidly after beginning of the exposure up to 1 h after the exposure was completed. A peak concentration of 1,836±863 μg/l was observed, the half-life in urine was 3.2 h. About 0.5% of the absorbed dose was excreted metabolically unchanged. An average dermal absorption of 5.5 mg cm−2 h−1 was calculated. Conclusions: The results of this study show that the percutaneous absorption of NMP may contribute significantly to the overall uptake of the solvent, e.g. in the workplace. Therefore, a biological monitoring of NMP exposed workers is essential for occupational-medical surveillance.
This is a preview of subscription content, log in via an institution to check access.
References
Åkesson B, Jönsson BAG (1997a) Major metabolic pathway for N-methyl-2-pyrrolidone in humans. Drug Metab Dispos 25:267–269
Åkesson B, Paulsson K (1997b) Experimental exposure of male volunteers to N-methyl-2-pyrrolidone (NMP): acute effects and pharmacokinetics of NMP in plasma and urine. Occup Environ Med 54:236–240
Åkesson B, Carnerup M, Jönsson BAG (2004) Evaluation of exposure biomarkers from percutaneous absorption of N-methyl-2-pyrrolidone. Scand J Work Environ Health 30:306–312
Akrill P, Cocker J, Dixon S (2002) Dermal exposure to aqueous solutions of N-methylpyrrolidone. Toxicol Lett 134:265–269
Anundi H, Lind ML, Friis L, Itkes N, Langworth S, Edling C (1993) High exposures to organic solvents among graffiti removers. Int Arch Occup Environ Health 65:247–251
Anundi H, Langworth S, Johanson G, Lind ML, Åkesson B, Friis L, Itkes N, Söderman E, Jönsson BAG, Edling C (2000) Air and biological monitoring of solvent exposure during graffiti removal. Int Arch Occup Environ Health 73:561–569
Bader M, Will W, Rossbacher R, Nasterlack M, Wrbitzky R (2003) N-Methyl-2-pyrrolidon – Arbeitsmedizinische Bedeutung und Toxikologie. Arbeitsmed, Sozialmed, Umweltmed 9:422–428
Greim H, Lehnert G (eds.) (1994) N-Methyl-2-pyrrolidon (Dampf). Maximale Arbeitsplatzkonzentrationen. Arbeitsmedizinisch-toxikologische Begründungen. Senatskommission zur Prüfung gesundheitsschädlicher Arbeitsstoffe. Deutsche Forschungsgemeinschaft. 20. Lieferung, Wiley-VCH, Weinheim
HSE (Health and Safety Executive): N-Methyl-2-pyrrolidone. Risk assessment document. EH72/10, ISBN 0717615286, HSE Books, Sudbury, UK 1997
Langworth S, Anundi H, Friis L, Johanson G, Lind ML, Söderman E, Åkesson B (2001) Acute health effects common during graffiti removal. Int Arch Occup Environ Health 74:213–218
Payan JP, Boudry I, Beydon D, Fabry JP, Grandclaude MC, Ferrari E, André JC (2003) Toxikokinetics and metabolism of N-[14C]-methyl-2-pyrrolidone in male Sprague–Dawley rats: in vivo and in vitro percutaneous absorption. Drug Metab Dispos 31:659–669
Ursin C, Hansen CM, Van Dyk JW, Jensen PO, Christensen IJ, Ebbehoej J (1995) Permeability of commercial solvents through living human skin. Am Ind Hyg Assoc J 56:651–660
Acknowledgements
The authors thank Mr Wolfgang Rosenberger for his excellent technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bader, M., Keener, S.A. & Wrbitzky, R. Dermal absorption and urinary elimination of N-methyl-2-pyrrolidone. Int Arch Occup Environ Health 78, 673–676 (2005). https://doi.org/10.1007/s00420-005-0008-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00420-005-0008-0